Open Label Trial of Fluoxetine for the Treatment of Depression in Patients With End Stage Renal Disease

Withdrawn before enrolling · Phase 4

Conditions studied: Depression

In brief

The purpose of this study is to test whether once-weekly prozac therapy leads to reduction in depression in patients requiring kidney dialysis.

Key facts

Study ID

NCT00573547

Run by

Creighton University

People needed

0

Starts

2007-02-01

Expected to finish

2008-08-01

Last updated by the study team

2011-08-16

Who can join

Age: 19 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of chronic renal failure and end stage renal disease
• Ongoing need for regular dialysis treatment
• Diagnosis of depression based on DSMIV
• Age tween 19-65 years

You may not qualify if…

• Inability to provide informed consent
• Medically or psychiatrically unstable, as defined by requiring inpatient treatment
• Pregnancy, nursing or refusal to use a reliable method of birth control in women
• Patients with known allergy to fluoxetine, or previous treatment failure of fluoxetine

Where it is running

• Creighton Department of Psychiatry — Omaha, Nebraska, United States
• Creighton University Department of Psychiatry — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.